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Abstract 24 
 25 
A high intake of fruits and vegetables (FV) has been associated with reduced risk of a number of 26 
chronic diseases, including cardiovascular disease.  The aim of this review is to describe the 27 
potential use of biomarkers to assess FV intake.  Traditional methods of assessing FV intake 28 
have limitations, and this is likely to impact on observed associations with disease outcomes and 29 
markers of disease risk. Nutritional biomarkers may offer a more objective and reliable method 30 
of assessing dietary FV intake. Some single blood biomarkers, such as plasma vitamin C and 31 
serum carotenoids, are well established as indicators of FV intake. Combining potential 32 
biomarkers of intake may more accurately predict overall FV intake within intervention studies 33 
than the use of any single biomarker. Another promising approach is metabolomic analysis of 34 
biological fluids using untargeted approaches to identify potential new biomarkers of FV intake.  35 
Using biomarkers to measure FV intake may improve the accuracy of dietary assessment.  36 
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Introduction 37 
 38 
Fruit and vegetables and health 39 
Diets rich in fruit and vegetables (FV) have been linked with a reduced risk of chronic 40 
disease(1,2).  The evidence is particularly strong for cardiovascular disease(1-4), is weaker for both 41 
diabetes and cancer(2,5-10), and is relatively consistent for specific cancer sites(10).  FV are 42 
micronutrient and fibre-rich and therefore are recommended across all dietary guidelines(11-14).   43 
 44 
Although the evidence linking increased fruit and vegetable intake with a reduced risk of 45 
cardiovascular disease is consistent and relatively strong, it is largely based on observational 46 
studies(1-3), with few randomised controlled trials with clinically-relevant endpoints(3).  This 47 
observational evidence relies on traditional dietary assessment of fruit and vegetable intake, with 48 
the majority of studies using a food frequency questionnaire(2,3,9).    49 
 50 
Assessment of FV intake 51 
Accurate estimate of dietary intake can be challenging and traditional methods have been shown 52 
to be prone to both random and systematic errors.  In terms of the specific problems associated 53 
with measuring fruit and vegetable intake through traditional methods, FV have been shown to 54 
be particularly prone to over-reporting, as participants know that they are known to be health-55 
promoting foods and therefore tend to exaggerate usual intake(15,16).  A second reason which may 56 
impact on the accuracy of reporting is that, to report consumption of a particular number of 57 
portions per day requires a knowledge of what constitutes a portion of a range of FV, and such 58 
knowledge of what constitutes a portion has been recently shown to be lacking amongst a 59 
population of low FV consumers(17). 60 
 61 
Accurate dietary assessment is extremely important for confirming the associations between 62 
overall FV intake and chronic disease risk and to inform quantitative dietary guidelines.  Indeed, 63 
the optimum level of FV intake for health protection is still a topic of debate(18,19).  Accurate 64 
dietary assessment is also needed to help elucidate if different types of FV have different health-65 
promoting properties.  For example, while the evidence for an association between increased 66 
overall fruit and vegetable intake and diabetes risk is equivocal, specific fruits and vegetables 67 
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might be associated with risk, for example leafy green vegetables and diabetes risk(6-8).  There is 68 
also some debate over whether fruit juice has less benefit to health than other forms of fruit(20).  69 
Furthermore, the effect of particular cooking and processing methods on micronutrient content, 70 
and micronutrient bioavailability and the resulting effects on health are still uncertain(21).  71 
Finally, the concept of the need to consume a variety of FV, and the association between FV 72 
variety and health has been a focus of recent interest(22-24), but, again, to determine the true value 73 
of variety does rely on accurate dietary assessment methods.   74 
 75 
The importance of dietary assessment method when determining the association between FV 76 
intake and disease risk is exemplified by the work of Bingham et al(25), who examined the 77 
association between fruit and vegetable intake and ischaemic heart disease (IHD) risk, in a cross-78 
sectional analysis of the EPIC Norfolk Cohort Study.  Whilst there were strong associations 79 
between vitamin C intake assessed by food diary and plasma vitamin C status, coefficients were 80 
attenuated for vitamin C intake assessed by FFQ.  Similarly, when examining risk of IHD, 81 
plasma vitamin C and fruit and vegetable intake assessed by food diary were associated with risk 82 
of IHD, but not fruit and vegetable intake assessed by FFQ(25).  Therefore the choice of dietary 83 
assessment method can affect the observed association with disease risk, and selection of an 84 
appropriate method is vital.  The fact that a food diary and plasma vitamin C reflect recent 85 
intake, whilst an FFQ will typically reflect intake over the previous year, is likely to have a 86 
bearing on diet-disease associations in observational studies and highlights the need to consider 87 
the time scale of the various intake or status assessment methods must be considered(26). 88 
 89 
Thus, there is a need to explore and develop new methods of accurately estimating FV in order to 90 
better capture intake and be able to answer important research questions, such as those above, by 91 
allowing better evaluation of the association between intake and disease risk, and the 92 
measurement of compliance in intervention studies. 93 
 94 
Biomarkers of FV intake 95 
As outlined above, traditional methods of assessing FV consumption have significant limitations, 96 
and an alternative, more objective way of estimating FV intake may be to measure levels of 97 
compounds found in FV in biological samples, such as plasma, serum and urine.  The use of 98 
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biomarker methods in nutritional epidemiology in general has developed greatly in the last 99 
twenty years, with Bingham stating in 2002(27) that, “The collection of biological samples to 100 
improve and validate estimates of exposure, enhance the pursuit of scientific hypotheses, and 101 
enable gene-nutrient interactions to be studied, should become the routine in nutritional 102 
epidemiology.”  However, there are knowledge gaps, and in 2007 the Institute of Medicine 103 
recognised the lack of nutritional biomarkers, and confirmed a need for both biomarkers that can 104 
predict functional outcomes and chronic diseases, and those that can improve dietary assessment, 105 
but which are non-invasive, inexpensive and specific (28).  Hedrick et al.(29) reacted to this 106 
recommendation, suggesting a need to emphasize the development of biomarkers for evaluating 107 
adherence to national recommendations for specific food groups, e.g. wholegrains, fruit and 108 
vegetables. 109 
 110 
Biomarkers are constituents in the blood, urine or saliva that can be used to indicate dietary 111 
exposure and compare this to intake estimated by dietary assessment.  Depending on the food 112 
group and particular marker used, biomarkers can be classified into three main classes: recovery 113 
biomarkers are based on the total excretion of the marker over a specific time period and can 114 
estimate absolute intake, but only a few of these recovery biomarkers exist in nutrition, e.g. 115 
urinary potassium and urinary nitrogen(30).    A further class of markers are predictive markers – 116 
these have incomplete recovery, but have a stable, time-dependent and strong association with 117 
intake, the main example being urinary sucrose and fructose as a marker of sugar intake(31).  118 
Concentration markers cannot estimate absolute intake, but are correlated with intake and 119 
therefore can rank intake of specific nutrients(30), while replacement biomarkers are closely 120 
related to concentration biomarkers, but are specifically where information from food databases 121 
is unsatisfactory or unavailable(15).  A number of potential biomarkers of FV intake have been 122 
suggested, which are compounds found within FV, including a range of serum carotenoids 123 
(lutein, zeaxanthin, β-cryptoxanthin, α- and β-carotene and lycopene), and plasma vitamin C, but 124 
also urinary potassium, flavonoids in both urine and serum, and glucosinolates.  All of these 125 
biomarkers of FV intake would be classified as concentration markers, therefore they will not 126 
reflect exact dietary intake but are likely to be highly correlated with intake. 127 
 128 
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Vitamin C and carotenoids are the most commonly used biomarkers, but the complexity of the 129 
FV food group makes these compounds potentially less useful as biomarkers of the overall food 130 
group, because of the variability of content within different fruit and vegetables(30).   For 131 
example, the amount of vitamin C found within one portion of green pepper is equivalent to that 132 
found in around 20 portions of carrots and, conversely, the amount of total carotene found in one 133 
portions of carrots is equivalent to that found in more than 45 portions of green pepper(30).  134 
Kuhnle concluded that, given this variability, it is important to use a combination of biomarkers 135 
or to develop new biomarkers, for example, total phenols has been suggested as a potential 136 
biomarker which, unlike vitamin C and carotenoids, has much lower variation across different 137 
types of fruits and vegetables(30).  However, the use of total phenols as a biomarker of FV intake, 138 
while plausible based on food analysis, has yet to be explored in detail in human studies(30,32). 139 
 140 
Two separate systematic reviews have examined the use of FV biomarkers used in human 141 
intervention studies.  The first, published in 2011 by Baldrick et al.(33), aimed to examine the 142 
utility of the main biomarkers of FV intake to act as objective indicators of compliance in dietary 143 
intervention studies.  Therefore, this review was particularly focused on identifying compliance 144 
markers for intervention studies and reviewed usual practice in this area.  The search identified a 145 
total of 95 studies as suitable for inclusion according to pre-defined criteria and classified the 146 
interventions as being whole diet interventions, individual fruit and vegetable intervention 147 
studies or mixed fruit and vegetable studies.  Data was extracted and summarised for each study 148 
type.   This review concluded that, it was rarely possible to rely on assessment of a single 149 
biomarker as an indicator of dietary change in human intervention studies, but that single 150 
biomarkers could be good predictors of single classes of FV e.g. quercetin has been 151 
demonstrated to be a reasonable indicator of onion consumption.  Similarly, for “fruit only” 152 
intervention studies, assessment of vitamin C alone may suffice.  However, the authors 153 
concluded that, given the complexity of FV, and the large number of bioactive compounds they 154 
contain, a panel of biomarkers should be measured in FV trials, and this was likely to include a 155 
panel of carotenoids and vitamin C, but that further research should continue to explore more 156 
novel biomarker approaches(33). 157 
 158 
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A more recent systematic review, in contrast to the more qualitative review of Baldrick et al.(33), 159 
examined plasma vitamin C and serum carotenoids as indicators of FV intake, conducting both a 160 
SR and meta-analysis of RCTs and examining their comparative validity(34).  Nineteen fruit and 161 
vegetable interventions, with 1382 participants in total, measures at least one biomarker and nine 162 
trials, with n=667 participants, measured the five main carotenoids (lutein, β-cryptoxanthin, α-163 
carotene, β-carotene and lycopene and vitamin C.  Vitamin C and carotenoids (except lycopene) 164 
were responsive to general changes in FV intake at the group level, but there was no clear 165 
evidence of dose-response, so that those groups consuming higher number of portions of FV did 166 
not have more marked increases in these biomarkers.  There was also no convincing evidence 167 
that any single biomarker was more responsive than others, with all CIs overlapping, whilst there 168 
was high heterogeneity in responses, suggesting a lack of consistency in the size of response 169 
between studies. Owing to the high heterogeneity and lack of dose-response, the authors 170 
concluded that individual-level biomarker responses would be highly variable and could not be 171 
relied on(34).  Moreover, the RCTs included in the SR were of low quality, as assessed using the 172 
GRADE system.  This is not unexpected, as blinding is not possible in these whole food studies, 173 
while many of the trials included were not originally designed to develop biomarkers and 174 
therefore included participants consuming nutritional supplements and those who smoked, or did 175 
not collect samples in the fasting state.  Few trials stated whether there was allocation 176 
concealment, and the level of dietary control or  monitoring of adherence was low, leading to 177 
uncertainty about actual FV intake, which is crucial for biomarker response.  As with the 178 
previous systematic review, the authors concluded that further work is required to understand the 179 
determinants of biomarker variation among individuals(34).  180 
 181 
Novel biomarker approaches 182 
Given the challenges of the complexity of the FV food group, a number of novel biomarker 183 
approaches have been suggested.  It is possible to consider the assessment of a range of 184 
biomarkers and statistically combining them to better predict overall FV intake.  One approach to 185 
this is simply to sum individual biomarkers, e.g. carotenoids, to give a total carotenoid figure(35), 186 
but this leads to the total being dominated by the carotenoids present at the highest 187 
concentrations, e.g. lycopene.  To overcome this potential issue, Cooper et al.(36) have recently 188 
summed the biomarkers identified within a previous systematic review as most likely to respond 189 
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to increased FV intake(33), and calculated the sum of standardised variables of vitamin C, beta-190 
carotene and lutein, examining resulting associations with type 2 diabetes risk in the EPIC-191 
Norfolk study(36).  192 
 193 
McGrath et al.(37) have examined the effect of increased FV intake on biomarkers of FV 194 
consumption, both singly and in combination, but using data from dietary intervention studies 195 
and applying more complex statistics to combine the biomarkers.  They conducted the BIOFAV 196 
study, a tightly controlled FV dietary intervention (all food provided, and two meals per day on 197 
weekdays consumed under supervision) in low FV consumers.  A total of 30 participants, who 198 
usually consumed fewer than two portions of FV per day, were randomised to either 2, 5 or 8 199 
portions of FV per day for four weeks.  Blood and urine samples were collected at baseline and 200 
four weeks, and plasma vitamin C and serum carotenoid analysis conducted.  A combined model 201 
containing all carotenoids and vitamin C, when predicting allocated FV group, was a better fit 202 
than a model containing vitamin C only (P<0.001) or lutein only (P=0.006).  The C-statistic was 203 
lower in the lutein only model (0.85) and the vitamin C model (0.68) than the full model 204 
(0.95)(37). 205 
 206 
The authors then applied this approach to three other previously conducted FV interventions.  207 
They observed a similar pattern of results, but the differences between the combined biomarker 208 
and individual biomarker models were less marked, perhaps due to the lower levels of dietary 209 
control in these other studies(37).  This approach needs to be replicated, and the effect of adding 210 
additional potential biomarkers, e.g. urinary flavonoid excretion, to the models to potentially 211 
increase the predictive capacity of the model needs to be explored.  Whether such an approach 212 
has utility in observational studies, also needs to be tested.  An issue is that examining the 213 
potential of a combined biomarker panel in observational studies will require a “true” measure of 214 
FV intake to compare the biomarker against, and most observational studies will have used FFQ-215 
based data collection, which may not be accurate enough to reflect intake comparable to the 216 
timescale of the biomarker, i.e. reflect recent intake. 217 
 218 
Other studies have also explored the combined biomarkers approach, and have similarly 219 
demonstrated an indication of its utility, although each study has used different biomarkers and 220 
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approached the “combining” in a different way.  Analysis of the FLAVURS study, a study 221 
testing sequential increases of 2.3, 3.2, and 4.2 portions of FV every 6 weeks across 18 weeks in 222 
n = 154 male and female participants at increased risk of CVD, suggested that an integrated 223 
plasma biomarker (including vitamin C, total cholesterol–adjusted carotenoids, and FRAP 224 
values) was better correlated with FV intake (r = 0.47, p<0.001) than individual biomarkers(38).  225 
Inclusion of urinary potassium into the integrated biomarker panel did not further improve the 226 
correlation.  This integrated plasma biomarker could therefore, the authors suggest, be used to 227 
distinguish between high and moderate FV consumers.  No further indicators of model 228 
performance were included, which makes further comparisons with other studies difficult.   229 
 230 
In another study, a prediction model was developed from 12 FV intervention studies(39).  The 231 
prediction model was developed based on a total of 526 male and female participants and was 232 
conducted as an individual participant data meta-analysis examining FV intake both including 233 
and then excluding fruit and vegetable juices.  What was also important was that adjustments 234 
were included for important potential characteristics, such as age, BMI and smoking, that may 235 
have affected biomarker response, and this is the only study combining biomarkers to have 236 
explored the effect of such adjustment to date.  Measures of performance for the prediction 237 
model were calculated using cross-validation.  The final prediction model included carotenoids, 238 
folate and vitamin C, and these were positively correlated with FV intake(39).  For the prediction 239 
model of fruit, vegetable and juice intake, a reduced model which included only statistically 240 
significant predictors, selected using multivariable fractional polynomials performed best.  For 241 
this model, a number of measures of performance were presented: the root mean squared error 242 
(RMSE; 258.0 g, the correlation between observed and predicted intake (0.78) and the mean 243 
difference between observed and predicted intake (- 1.7 g limits of agreement: - 466.3, 462.8 g). 244 
For the prediction of fruit and vegetable intake (excluding juices), the RMSE was 201.1 g, the 245 
correlation was 0.65 and the mean bias was 2.4 g (limits of agreement: -368.2, 373.0 g). The 246 
authors concluded that these models could be used to predict ranking of FV intake when 247 
validating questionnaires or to estimate FV intake at the group level.  However, low levels of 248 
agreement meant that the prediction model should not be used to estimate individual intake(39). 249 
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Therefore combining already known biomarkers of FV intake may be useful in improving the 250 
use of biomarkers to accurately estimate FV intake, but only a limited number of studies have, to 251 
date, examined this approach.   252 
Metabolomics is an emerging analytical technique that identifies and quantifies small 253 
metabolites(40,41).  Traditional biomarker approaches have assessed mainly the concentration in 254 
biofluids of phytochemicals measured previously in uncooked FV.  In contrast,  metabolomics 255 
has been used to  identify biotransformation products (for example glucuronide and sulphate 256 
conjugates or colon microbiota fermentation products) of diet-derived chemicals that are both 257 
stable, more abundant  and easily quantified by  standardised methods(42,43).  The ability to 258 
comprehensively analyse metabolites in biological fluids to look for novel dietary exposure 259 
biomarkers in an untargeted way is likely to enhance the ability of researchers to characterise 260 
dietary exposure, with many potential applications in nutritional epidemiology.  Challenges, 261 
however, exist, both in terms of the technology required to identify unknown metabolites and to 262 
deal with the large amounts of data produced during this type of analysis.  Although a number of 263 
studies have examined specific FV classes and used metabolomics to identify potential novel 264 
biomarkers, e.g. proline betaine as a biomarker of citrus intake(44,45), and S-methyl-L-cysteine 265 
sulphoxide (SMCSO) and metabolic derivatives as biomarkers of cruciferous vegetable 266 
intake(46), the use of metabolomics to assess overall FV intakes is, as yet, uncertain.  267 
 268 
Another approach that has been suggested is the optical detection of carotenoids in the skin using 269 
a range of methods, including resonance Raman spectroscopy, reflection spectroscopy and 270 
pressure-mediated reflectance spectroscopy(47).  Such a method would be non-invasive, simple 271 
and relatively inexpensive and would provide estimates on the spot without the need for 272 
collection of biological samples which are then analysed in a laboratory.  Whether such a 273 
technique is sensitive enough to pick up changes in FV intake within normal diet ranges remains 274 
to be established.  However, a recent study as demonstrated a statistically significant association 275 
between carotenoid intake and skin carotenoids in 9-12 year old children, hence the authors 276 
suggest the potential for such a non-invasive method to measure FV intake in this population(48). 277 
 278 
11 
 
Furthermore, the use of multiple dietary assessment methods and/or biomarker approaches in 279 
combination may strengthen the investigation of diet-disease relationships and increase statistical 280 
power(49,50).  The approach has then been used in relation to the carotenoids lutein and 281 
zeaxanthin, the carotenoids, which are potential biomarkers of FV intake, and are of particular 282 
interest in eye disease as they are the only components of the macular pigment(51).  In their study, 283 
Freedman et al.(51) explored the difference in statistical power produced when examining either 284 
(i) self-reported dietary intake of lutein and zeaxanthin from a FFQ, (ii) serum lutein and 285 
zeaxanthin concentration, or (iii) a combined method summing the ranking of participants from 286 
(i) and (ii).  The combined measure, when examining the association between lutein and 287 
zeaxanthin and risk of nuclear cataracts, provided higher statistical significance that the dietary 288 
measure or serum measure alone.  The authors suggest a saving of 8-53% over analysis with 289 
dietary intake alone and 6-48% for serum level alone in terms of required sample size(51).  Such 290 
an increase in power, or reduction in required sample size is sizeable and indicates the potential 291 
utility of this approach.   292 
 293 
Considerations when using biomarkers of FV intake 294 
There are a number of important considerations when using biomarker approaches, and these 295 
will be common to all biomarkers.  Consideration of the chronology of exposure is important for 296 
both traditional dietary assessment and biomarkers, with the likely time frame covered by 297 
different dietary assessment methods and biomarkers being considered when comparing methods 298 
(Figure 1).  There are a number of further factors which will affect the ability of biomarkers to 299 
predict intake.  These have been summarised by Jenab et al.(15) for dietary assessment and 300 
biomarkers in general (adapted in Figure 2), and will include a range of pre-analytical factors 301 
which need to be considered(52,53).   302 
 303 
Specifically, vitamin C is a particularly labile vitamin and therefore sample collection and 304 
stabilisation has to be conducted carefully, according to protocols which involve the precipitation 305 
of proteins, usually with metaphosphoric or trichloroacetic acid(54,55).  Such stabilisation is not 306 
commonly carried out within large-scale epidemiological studies.  Similarly, carotenoids can be 307 
light-sensitive, and therefore exposure to light during processing and storage should be 308 
minimised(56).   309 
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 310 
Genetic differences in biomarker responses have been observed, although to date these have only 311 
been analysed within observational studies(57,58).  For example, Timpson et al. examined 312 
variation at the SLC23A1 locus in five independent population studies and found that each 313 
additional rare allele was associated with a reduction in circulating ascorbic acid concentrations 314 
(-5.98 [95% CI: -8.23, -3.73] micromol/L, P = 2.0 x 10(-7) per minor allele)(57).  Similarly, 315 
carotenoid status has been suggested to depend on range of genotypes, including phase 2 enzyme 316 
glutathione S-transferase M1 and T1 polymorphisms, and this has been reviewed(58).  The effect 317 
of such polymorphisms on biomarker responses within FV intervention studies is not known, but 318 
to test this will require careful study design consideration and likely increase in required sample 319 
size.   320 
 321 
Differences in biomarker responses have been observed based on baseline concentration(15), 322 
inflammation(59), status of other nutrients, including other carotenoids(60), BMI(61), and 323 
smoking(62).  For example, plasma carotenoids and vitamin C were less strongly associated with 324 
dietary intake in obese older subjects than in those of normal weight(61).  Furthermore, plasma 325 
vitamin C tends to plateau at higher levels of intake (>120 mg/day), and therefore may not 326 
accurately reflect higher exposure(63).  A recent study examining carotenoids as biomarkers of 327 
FV intake in men and women, and using data from FV interventions, suggested that plasma β-328 
cryptoxanthin and lutein concentrations were reliable biomarkers of FV consumption, but that 329 
there were significant gender differences in biomarker response following FV consumption(64), 330 
suggesting that gender must be considered when monitoring biomarker responses.  These factors 331 
are also considered in Figure 2. 332 
 333 
What has been less fully explored and which will be challenging, is whether biomarkers can ever 334 
be sensitive enough to pick up on differences in response by FV class, cultivar, production, 335 
processing and storage factors, which may impact on micronutrient content of the specific fruit 336 
or vegetable, and, affect health status.  For example, cooking of fruit and vegetables leads to a 337 
reduction in vitamin C content(65), but the degree of loss will depend on the cooking procedure 338 
and length of cooking time.  Miglio et al.(66) examined the effect of different cooking methods on 339 
phytochemical properties, total antioxidant capacity and physicochemical properties of carrots, 340 
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courgettes and broccoli, and highlighted that the modifications by cooking are strongly 341 
dependent on the vegetable species.  Similarly the consumption of fat alongside carotenoid-rich 342 
foods increases bioavailability of the carotenoids(67).  While it is perhaps unlikely that FV 343 
biomarkers will ever be sensitive enough to measure the impact of some of these factors, what is 344 
likely is that there will be an improvement of accuracy in terms of global FV assessment. 345 
 346 
Conclusion 347 
In conclusion, eating more fruit and vegetables is associated with better health status, but some 348 
uncertainties exist regarding the optimum number of portions, type, cooking and processing 349 
methods and effects on specific disease/health outcomes, particularly for different types of FV, 350 
and to what extent variety is important.  Accurate assessment of dietary intake is, in general, 351 
difficult, and there are particular challenges for FV as it is a complex food group, with a range of 352 
bioactive compounds.  Novel biomarker methods are a focus of interest and are potentially 353 
important in order to improve the accuracy of intake assessment and so advance research related 354 
to FV. 355 
 356 
 357 
  358 
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 544 
Figure 1 Timescale of nutritional biomarkers from different biological sources (adapted from Kuhnle(30)) 545 
 546 
  547 
FV biomarker discovery has largely 
focused on serum/plasma and urine, 
therefore only recent intake (within the 
last week) can be measured using 
these approaches. Assessment of 
longer term intake using biomarkers 
measured in teeth and hair is unlikely to 
be possible for this food group. 
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Figure 2 Factors affecting nutritional biomarker response (adapted from Jenab et al.(15)), with specific examples added for proposed 548 
FV biomarkers 549 
 550 
General type of factor Specific factor relevant for FV Reference 
Genetic variability Genetic differences in vitamin C and carotenoid 
biomarker response 
(57, 58) 
Lifestyle or physiologic 
factors 
Gender, inflammation, smoking, BMI (59, 61, 62, 64) 
Dietary factors Baseline concentration of biomarker, status of 
other carotenoids, intake of other nutrients (e.g. 
fat intake increases bioavailability of 
carotenoids), cooking and processing of foods 
(15, 60, 65, 66, 
67) 
Biological sample Stability of sample (requires acid stabilisation for 
vitamin C, light protection for carotenoids),  
(54-56) 
Analytical methodology Plasma vitamin C biomarker response only linear 
at lower concentrations 
(63) 
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